Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.
Association between smoking and cognitive impairment in multiple sclerosis.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
The Development of Prophylactic and Therapeutic EBV Vaccines.
Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls.
Relationship Between Botulinum Toxin, Spasticity, and Pain: a Survey of Patient Perception.
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis.
Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Demyelinating CNS Lesions in a Teenager.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
Acute Disseminated Encephalomyelitis in Children and Adolescents: A Single Center Experience.
Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
Hunting for autoantibodies in multiple sclerosis.
[Neurological manifestations of Behçet's disease.]
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Targeting the B7 Family of Co-Stimulatory Molecules : Successes and Challenges.
Long-term safety of azathioprine therapy in multiple sclerosis.
Evaluation of Multi-Atlas Label Fusion for In Vivo MRI Orbital Segmentation.
Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.

Pages